StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Ironwood Pharmaceuticals's enterprise value was $715.68M on Nov 10, 2026, against $428.97M a year earlier. Over the last 5 years it ranged from -$11.54M to $2.10B, with a median of $914.86M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$715.68M+75.5%
2025Dec 31, 2025$407.82M-34.3%
2024Dec 31, 2024$620.66M-62.9%
2023Dec 29, 2023$1.67B+26.3%
2022Dec 30, 2022$1.33B-8.7%
2021Dec 31, 2021$1.45B-4.2%
2020Dec 31, 2020$1.52B-22.2%
2019Dec 31, 2019$1.95B+320.0%
2017Jan 31, 2017$463.78M-6.6%
2016Dec 30, 2016$496.36M-55.7%
2015Dec 31, 2015$1.12B-47.6%
2014Dec 31, 2014$2.14B+116.9%
2013Dec 31, 2013$985.52M-6.4%
2012Dec 31, 2012$1.05B-6.1%
2011Dec 30, 2011$1.12B–
2010Dec 31, 2010-$48.65M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?